EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impact of Viloxazine Extended-Release Capsules (Qelbree®) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics

Zhao Wang, Tesfaye Liranso, Zulane Maldonado-Cruz, Alisa R Kosheleff, Azmi Nasser

Clinical Drug Investigation · 2024

DOI: 10.1007/s40261-024-01356-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Drug Investigation, 2024. Verfasst von Zhao Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA. zwang@supernus.com. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2D6, Delayed-Action Preparations, Viloxazine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP2D6Delayed-Action PreparationsViloxazineFemaleHumansMaleCaffeineCapsulesCytochrome P-450 Enzyme SystemDextromethorphanHealthy VolunteersMidazolamPolymorphism, Genetic

Substanzen

CaffeineCapsulesCytochrome P-450 CYP2D6Cytochrome P-450 Enzyme SystemDelayed-Action PreparationsDextromethorphanMidazolamViloxazine

Autor:innen und Institutionen

  • Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA. zwang@supernus.com.
  • Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA.

Zitieren

APA

Wang, Z., Liranso, T., Maldonado-Cruz, Z., Kosheleff, A. R., & Nasser, A. (2024). Impact of Viloxazine Extended-Release Capsules (Qelbree®) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics. Clinical Drug Investigation. https://doi.org/10.1007/s40261-024-01356-0

Vancouver

Wang Z, Liranso T, Maldonado-Cruz Z, Kosheleff AR, Nasser A. Impact of Viloxazine Extended-Release Capsules (Qelbree®) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics. Clinical Drug Investigation. 2024. doi:10.1007/s40261-024-01356-0

BibTeX
@article{Wang2024,
  author = {Wang, Zhao and Liranso, Tesfaye and Maldonado-Cruz, Zulane and Kosheleff, Alisa R and Nasser, Azmi},
  title = {Impact of Viloxazine Extended-Release Capsules (Qelbree®) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics},
  journal = {Clinical Drug Investigation},
  year = {2024},
  doi = {10.1007/s40261-024-01356-0}
}
Kostenlos starten →